America’s Medical Establishment Is in Denial on the Dangers of Gender Transition

On this side of the Atlantic, the Cass Review has fallen on deaf ears.

Dr. Hilary Cass released her final report for England’s National Health Service two months ago, clearly demonstrating that puberty-blockers and hormonal treatments for trans-identified children and teens lack supporting evidence. NHS England has now banned puberty-blockers in clinical care and will be restricting their use to research settings. Yet U.S. medical leaders have responded with silence, inaction, or both, proving that the physical and emotional well-being of youth has taken a back seat to social and political agendas.